AtlasOral CancerOral Squamous Cell Carcinoma

Oral Cancer

Oral Squamous Cell Carcinoma

aka Oral SCC · OSCC

Malignant epithelial neoplasm; > 90% of all oral malignancies. Sixth most common cancer worldwide.

§ overviewOverview

Malignant epithelial neoplasm; > 90% of all oral malignancies. Sixth most common cancer worldwide.

§ etiologyEtiology

  • 01Tobacco (smoked & smokeless)
  • 02Alcohol (synergistic with tobacco)
  • 03Areca nut
  • 04HPV 16 (oropharyngeal)
  • 05Chronic trauma
  • 06Immunosuppression

§ epidemiologyEpidemiology

M > F, > 50 years. South Asia highest incidence globally.

§ clinicalClinical Features

  • 01Non-healing ulcer > 3 weeks
  • 02Indurated margins, everted edges
  • 03Fixed to underlying tissues
  • 04Cervical lymphadenopathy
  • 05Common sites: lateral tongue, floor of mouth, gingiva

§ differentialDifferential Diagnosis

  • 01Traumatic ulcer
  • 02Tuberculous ulcer
  • 03Syphilitic gumma
  • 04Deep fungal infection

§ histopathHistopathology

  • 01Invasive nests and cords of atypical squamous epithelium
  • 02Keratin pearls (well-differentiated)
  • 03Nuclear pleomorphism, mitotic figures
  • 04Broders' grading I–IV

§ investigationsInvestigations

  • 01Incisional biopsy — gold standard
  • 02CECT / MRI — local extent
  • 03USG neck + FNAC — nodal disease
  • 04PET-CT — distant metastasis / recurrence
  • 05Chest imaging

§ stagingStaging

AJCC 8th ed TNM — DOI (depth of invasion) and ENE (extra-nodal extension) incorporated.

§ treatmentTreatment

  • 01Stage I–II: single-modality — surgery OR radiotherapy
  • 02Stage III–IV: composite resection + neck dissection + adjuvant CRT
  • 03Neck: elective SND for cN0 with DOI > 3 mm
  • 04Targeted / immunotherapy: cetuximab, pembrolizumab, nivolumab for recurrent/metastatic

§ complicationsComplications

  • 01Loco-regional recurrence
  • 02Distant metastasis (lung most common)
  • 03Second primary (field cancerisation)

§ prognosisPrognosis

5-year survival: Stage I 80%, Stage IV < 30%.

§ preventionPrevention

  • 01Tobacco/alcohol cessation
  • 02HPV vaccination
  • 03Regular oral screening

§ vivaBDS Viva Questions

  • 01Define depth of invasion and its prognostic significance.
  • 02Indications for elective neck dissection in cN0 OSCC.

§ pearlsClinical Pearls

  • 01Any oral ulcer that fails to heal within 3 weeks must be biopsied.

§ mnemonicsMnemonics

  • 01FEAR — Fixed, Everted, Anaesthetic, Rolled edges

Draft — pending faculty review. Educational use only; verify against current guidelines and primary sources before clinical application.